News
Advertisement
Advertisement
Advertisement
Transaction with special purpose acquisition company totals $138 million.
The latest industry happenings, all in one place.
RWE can augment, extend, or enrich the findings from clinical trials to provide valuable evidence to support the development programs for product approvals.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Our Top 5 Most Read Articles in 2025
3
ACT Brief: AI-Enabled Workflow Automation, Subcutaneous Lunsumio VELO Approval, and Pan-KRAS Early-Stage Development
4
ACT Brief: FDA Approval of Oral Wegovy, 2025’s Most-Read ACT Coverage, and Data Quality as the Foundation for AI
5